#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14654	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2130	683.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1660	1660	T	843	T,C	424,360	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14654	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2130	683.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1394	1394	C	884	C	820	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27290	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3544	767.7	0	.	n	.	0	T695C	SNP	695	695	T	1003	1003	C	839	C,T	781,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27290	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3544	767.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1645	1645	A	932	A	866	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27290	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3544	767.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2279	2279	C	870	C	806	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27290	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3544	767.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2353	2353	A	916	A,C	862,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27290	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3544	767.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2905	2905	C	849	C,T	792,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2038	folP	855	855	100.0	folP.l15.c4.ctg.1	1584	128.5	1	SNP	p	R229S	0	.	.	685	687	CGC	1080	1082	CGC	213;217;215	C;G;C	197;197;198	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4950	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3325	148.4	1	SNP	p	S91F	0	.	.	271	273	TCC	538	540	TCC	172;170;171	T;C;C	159;157;159	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4950	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3325	148.4	1	SNP	p	D95N	0	.	.	283	285	GAC	550	552	GAC	179;175;175	G;A;C,T	167;162;159,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4950	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3325	148.4	1	SNP	p	D95G	0	.	.	283	285	GAC	550	552	GAC	179;175;175	G;A;C,T	167;162;159,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1646	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1343	122.4	0	.	p	.	0	S32W	NONSYN	94	96	TCG	433	435	TGG	184;180;182	T;G;G	165;169;168	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1646	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1343	122.4	0	.	p	.	0	D79N	NONSYN	235	237	GAT	574	576	AAT	199;195;196	A,G;A;T	181,1;181;177	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1646	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1343	122.4	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	206;205;203	G;G;C	188;188;185	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	856	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	956	89.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5300	parC	2304	2304	99.83	parC.l6.c30.ctg.1	2906	181.8	1	SNP	p	D86N	0	.	.	256	258	GAC	523	525	GAC	238;241;245	G;A,G,C;C	219;217,1,1;226	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5300	parC	2304	2304	99.83	parC.l6.c30.ctg.1	2906	181.8	1	SNP	p	S88P	0	.	.	262	264	TCC	529	531	TCC	236;235;236	T;C;C	213;217;219	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4220	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2481	168.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1443	1445	GGC	198;194;193	G;G;C	178;178;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1168	1170	GCA	213;215;217	G;C;A	189;190;194	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1171	1173	ATC	218;218;218	A;T;C	193;194;193	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1183	1185	GTG	228;224;222	G;T;G	208;204;202	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1183	1185	GTG	228;224;222	G;T;G	208;204;202	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1687	1689	ACC	208;209;207	A;C;C	187;190;187	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1741	1743	GCG	190;192;194	G;C,G;G	173;157,1;167	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1741	1743	GCG	190;192;194	G;C,G;G	173;157,1;167	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1864	1866	GGC	170;170;167	G;G;C	159;155;152	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1873	1875	GGC	169;169;168	G;G;C	159;156;157	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4018	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	176.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1891	1893	CTG	163;162;162	C,G;T;G	124,3;114;122	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5634	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3066	183.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1642	1644	CCG	190;191;191	C,T;C;G	165,1;178;173	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2294	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1977	115.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	483	485	GGC	168;169;171	G,T;G;C,T	154,1;159;157,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2294	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1977	115.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	665	665	C	161	C	140	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	T18M	NONSYN	52	54	ACG	332	334	ATG	230;226;227	A;T;G	209;208;209	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	D41G	NONSYN	121	123	GAC	401	403	GGC	223;219;223	G;G;C	219;213;217	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	A142T	NONSYN	424	426	GCC	704	706	ACC	208;207;209	A;C;C,A	192;193;197,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	707	709	CAA	211;214;216	C;A;A	200;200;202	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	E212D	NONSYN	634	636	GAA	914	916	GAT	224;222;218	G;A;T	205;203;197	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	H213N	NONSYN	637	639	CAT	917	919	AAT	219;222;218	A;A,G;T	201;202,1;195	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	V215A	NONSYN	643	645	GTT	923	925	GCT	213;214;215	G;C;T	193;195;199	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	I218T	NONSYN	652	654	ATC	932	934	ACC	218;220;221	A;C;C	192;203;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	S220T	NONSYN	658	660	AGC	938	940	ACT	220;221;220	A,G;C;T	199,1;205;205	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1049	1051	ATG	208;208;207	A;T;G	198;201;200	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1052	1054	AGC	210;208;213	A;G;C,A	202;200;202,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1055	1057	GGT	214;215;216	G;G;T	203;204;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1169	1171	AAC	213;214;213	A;A;C	199;204;197	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.38	porB1b.l15.c17.ctg.1	1460	180.6	1	SNP	p	G120K	0	.	.	358	360	GGC	638	640	GGC	198;196;196	G,A;G,A;C,G	180,1;178,2;179,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10800	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4922	219.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1100	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	911	118.7	1	SNP	p	V57M	1	.	.	169	171	ATG	464	466	ATG	239;240;240	A;T;G	223;226;225	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	922	924	ACG	398;394;389	A;C;G,T	386;384;378,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	943	945	GAC	347;345;345	G,T;A;C	345,1;343;344	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	T190M	NONSYN	568	570	ACG	961	963	ATG	326;324;325	A;T;G	324;323;321	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	L194S	NONSYN	580	582	TTA	973	975	TCA	321;316;320	T;C;A	317;314;316	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1018	1020	CAG	354;356;357	C;A;G	350;353;353	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1039	1041	CTT	361;358;356	C;T;T	360;357;355	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1060	1062	AGT	388;396;398	A;G;T	380;386;382	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1129	1131	CCG	517;522;525	C;C;G	478;484;491	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1231	1233	TCG	566;568;565	T;C,A;G	520;517,1;516	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1402	1404	AAA	312;308;301	A;A;A	300;298;291	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1405	1407	AAG	294;287;284	A;A;G	285;279;277	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1420	1422	CAC	257;256;252	C;A;C	253;242;251	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1459	1461	GAA	245;240;242	G;A;A	244;240;242	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1537	1539	ACG	167;164;162	A;C,T;G	165;161,1;162	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1588	1590	ATT	248;245;245	A;T;T	237;234;236	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1591	1593	AGT	243;242;243	A;G;T,C	233;233;230,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1630	1632	CTA	284;284;287	C;T;A	269;270;272	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1672	1674	AAT	200;200;203	A;A;T	193;193;195	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1741	1743	TCA	275;274;271	T;C;A	261;261;255	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1765	1767	ATG	291;294;293	A;T;G	279;282;283	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2059	2061	ACC	586;591;589	A,T;C,T;C,T	549,1;555,1;552,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10762	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2619	409.4	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2155	2157	GAA	569;568;567	G;A;A	539;540;542	.	Tetracycline resistance
